Key points are not available for this paper at this time.
New understanding of medical and surgical risk factors, new methods for scientific diagnosis, and new pharmacological options for treatment are all shaping the way we approach female sexual dysfunction. Sildenafil (Viagra) and similar drugs to treat sexual function complaints are here to stay, and will provide a range of phenomenal opportunities as well as potential pitfalls. One of the major roles of sex educators and therapists in the new millennium will be to help to monitor and adjust the global application of pharmacotherapy. The issue is not the availability of medication to treat sexual complaints, but how it is applied. Sex educators and therapists will be called upon to join teams of physicians and help make comprehensive diagnoses—not only for women, but for men as well. The time has come to join forces with the physicians and release the vacuum in which these fields have existed. It is not about whose approach is better; it is about determining the best approach for each individual patient and offering them the best, most effective, and thorough treatment options. By working together and sharing in this new era of opportunities, sex educators and therapists can continue to effectively attend to what we do best: helping others reach their full sexual potential.
Berman et al. (Wed,) studied this question.